How PTSD Got Its Name — The Self-Medication Gap

Before PTSD existed as a diagnosis, Vietnam veterans had no clinical language for combat trauma. They were being misdiagnosed as paranoid schizophrenics, prescribed antipsychotics, dismissed as malingerers, and often self-medicated with cannabis, alcohol, and other substances. The story of how PTSD finally made it into the DSM is a story of veteran advocacy, and it is critical context for understanding veteran self-medication patterns today.

Before PTSD Had a Name

The DSM-I (1952) recognized "gross stress reaction" — a brief, largely situational response to extreme stress that was expected to resolve when the stressor was removed. The DSM-II (1968) eliminated it entirely, leaving no clinical framework for combat trauma just as the Vietnam War was generating unprecedented numbers of combat-exposed veterans.

The consequences were severe. Vietnam veterans with what we would now recognize as PTSD were typically:

• Misdiagnosed with paranoid schizophrenia (particularly when hypervigilance and intrusive memories were mistaken for psychotic symptoms)
• Prescribed antipsychotic medications that did not address trauma and had significant side effects
• Treated as "adjustment problems" or "character disorders"
• Dismissed as malingerers or drug-seekers when they described their symptoms
• Told that their experiences were "stress" that they should "get over"
• Denied disability benefits because no diagnostic category captured their condition

Veterans who tried to get help often encountered clinicians who did not understand combat, did not believe combat trauma could produce lasting symptoms, or who held stigmatizing attitudes toward returning Vietnam veterans. Many veterans concluded that the healthcare system had no help to offer and stopped seeking it.

The Self-Medication Context

In the vacuum left by the absence of a diagnosis, veterans turned to what was available. Alcohol was universally available. Cannabis was widespread and culturally normalized in the 1970s. Illicit drugs were accessible in many communities. Veterans used what they could find, not because cannabis or alcohol were optimal treatments, but because no other treatments were being offered.

This self-medication was not evidence that substances were effective — it was evidence that the system had failed. The distinction matters. Veterans who self-medicated in the 1970s were not making "informed choices about cannabis as medicine." They were using what they had access to because the clinical alternatives were nonexistent.

Jan Barry and Vietnam Veterans Against the War

In January 1970, Jan Barry, president of Vietnam Veterans Against the War (VVAW), wrote to psychiatrist Robert Jay Lifton requesting help. His message was direct:

"Guys are hurting."

This simple statement, coming from an organization founded by veterans for veterans, kicked off what would become the formal clinical movement to establish PTSD as a diagnosis. Barry and VVAW were not clinicians, but they understood what they were seeing in their fellow veterans — and they understood that the existing clinical framework was not equipped to help.

The Rap Groups

Lifton and Chaim Shatan, another psychiatrist sympathetic to antiwar concerns, began weekly "rap groups" at VVAW's New York office. These were not traditional therapy — they combined therapy with antiwar activism, and they took place outside formal clinical settings. The groups created a space where veterans could:

• Talk about their combat experiences without being dismissed or pathologized
• Recognize that their symptoms were shared by other veterans, not signs of personal weakness
• Process their experiences in a way that did not require them to accept a psychotic diagnosis
• Develop clinical descriptions of what they were experiencing that could feed back into psychiatric knowledge

The rap groups were both clinically and politically significant. They were early prototypes of peer-support trauma work, and they produced much of the qualitative data that fed the eventual PTSD diagnosis.

The "Post-Vietnam Syndrome" Op-Ed

On May 6, 1972, Chaim Shatan published "The Post-Vietnam Syndrome" on the New York Times op-ed page. This was the first major public description of what would eventually be called PTSD. Shatan outlined the characteristic symptoms — intrusive memories, hypervigilance, emotional numbing, sleep disturbance, guilt, difficulty with interpersonal relationships — and argued that they constituted a coherent psychological consequence of combat exposure rather than individual character flaws.

The op-ed reached a broad audience and began to shift public perception of Vietnam veterans. It also reached other clinicians who began to recognize similar patterns in their own patients.

Sarah Haley and the VA

VA social worker Sarah Haley in Boston documented that Vietnam veterans were being systematically misdiagnosed as paranoid schizophrenics at VA medical centers. Her 1974 paper "When the Patient Reports Atrocities: Specific Treatment Considerations of the Vietnam Veteran" was a landmark in clinical recognition of combat trauma.

Haley's work was particularly important because it documented what was happening inside the VA system — where most veterans were receiving care — and it showed that the misdiagnosis pattern was systematic rather than individual. This helped establish the case that institutional change, not just individual clinical adjustment, was needed.

DSM-III and the Formal Diagnosis (1980)

Their advocacy culminated in PTSD's inclusion in the DSM-III in 1980. This was a long process:

• Working groups of clinicians and researchers met for years to develop diagnostic criteria
• Opposition came from some psychiatrists who worried about "medicalizing normal distress" or creating malingering pathways for compensation-seekers
• Supporters pointed to the consistency of symptom patterns across multiple trauma types (combat, rape, disaster, accident) as evidence that a single diagnostic category was warranted
• The final DSM-III criteria required: exposure to a stressor "outside the range of usual human experience"; re-experiencing symptoms; numbing of responsiveness; and other specific symptoms

PTSD's entry into the DSM-III was a major event. It legitimized the experiences of millions of Vietnam veterans (and retrospectively validated veterans of earlier wars). It opened the door to evidence-based treatment development. It established a framework for disability compensation claims. And it provided the clinical language that veterans had been missing for decades.

The National Center for PTSD (1989)

The National Center for PTSD was created within the VA in 1989. It became the leading research and clinical training center for PTSD worldwide, developing many of the evidence-based treatments now used (prolonged exposure, cognitive processing therapy, EMDR adaptation for PTSD), publishing clinical practice guidelines, and training clinicians across the VA system.

The National Center for PTSD remains one of the most significant institutional resources for trauma treatment. Its existence represents the institutionalization of what VVAW, Lifton, Shatan, and Haley argued for: combat trauma is real, it deserves clinical attention, and veterans deserve care rather than dismissal.

The Self-Medication Gap Legacy

For the decade-plus before the PTSD diagnosis existed (roughly 1968–1980), veterans had no clinical language for their suffering — and many turned to cannabis, alcohol, and other substances to manage symptoms that lacked even a name. This is the critical self-medication context that shapes veteran cannabis use to this day.

Even after PTSD became a diagnosis, the self-medication pattern persisted for several reasons:

• Evidence-based treatments took years to develop and spread
• Access to VA mental health was inconsistent across facilities and eras
• Stigma around seeking mental health care remained (and remains)
• Veterans who had developed substance-based coping patterns often continued them even as treatment became available
• Treatment options for some conditions (sleep, nightmares, chronic pain) remained limited

Understanding this context helps explain why cannabis is not primarily a "medical choice" for many veterans — it is often a continuation of patterns that formed when clinical alternatives were unavailable.

Why This History Matters Now

• Veteran advocacy changes things. PTSD exists as a diagnosis because veterans demanded it. Current advocacy for cannabis policy reform continues this tradition.
• Self-medication without clinical alternatives produces long-term patterns. Addressing underlying conditions reduces self-medication; punishing self-medication without addressing underlying conditions does not.
• Diagnostic categories carry real consequences. Having a name for your suffering unlocks treatment, disability benefits, and community.
• Institutional change is slow but possible. The gap between what veterans need and what institutions provide has narrowed over decades, largely through advocacy.

Related Reading

• Vietnam & Golden Flow
• Post-9/11 Opioid Crisis
• Cannabis & PTSD Evidence
• Cannabis Use Disorder